 | |
- close
- close
|
Business Wire
Nov 17
Comment
Conceptus, Inc. (Nasdaq: CPTS), developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that Mark Sieczkarek, president and chief executive officer, will present at the Piper
Business Wire
Nov 9
Comment
Conceptus, Inc. (Nasdaq: CPTS), developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that the United Stated District Court, Northern District of California has denied
Business Wire
Nov 4
Comment
Conceptus, Inc. (Nasdaq: CPTS), developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that Mark Sieczkarek, president and chief executive officer, will present at the Lazard
Business Wire
Oct 29
Comment
Conceptus, Inc. (Nasdaq: CPTS), developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that the clinical success of the Essure® procedure will be highlighted at the 18th Annual
Stock Blog Hub
Oct 28
Comment
Conceptus, Inc. (CPTS) crushed analyst estimates after a very beneficial acquisition.
Company Description
Concept us makes a proprietary birth control product for women called Essure. The Essure procedure is permanent, done with out any...
newratings.com
Oct 23
Comment
NEW YORK, October 22 (newratings.com) - Analysts at Barrington Research upgrade Conceptus (ticker: CPTS) from "market perform" to "outperform." The target price is set to $23. [more]
StreetInsider.com
Oct 22
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Barrington+Research+Upgrades+Conceptus+%28CPTS%29+to+Outperform/5037206.html for the full story.
StreetInsider.com
Oct 21
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Conceptus+%28CPTS%29+Reports+Q3+EPS+%240.20%2C+Beats+By+11c%3B+Guides+Q4+EPS/5034781.html for the full story.
Business Wire
Oct 21
Comment
Conceptus, Inc. (Nasdaq: CPTS), developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today reported financial results for the three and nine months ended September 30, 2009. Net sales for the
Business Wire
Oct 20
Comment
Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that Mark Sieczkarek, president and chief executive officer, will present at the 20th Annual
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
CPTS AT A GLANCE
References
| ||||||
|
|
